76 - Invasive Fungal Infections and COVID-19

Thursday, October 20, 2022

1:45 PM – 3:00 PM US ET

Location: 151 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Jeniel Nett, MD, PhD

Associate Professor
University of Wisconsin-Madison
Madison, WI, United States

Disclosure(s): No financial relationships to disclose
Dimitrios Kontoyiannis, MD

Professor, Infectious Diseases
Infectious Diseases, Infection Control and Employee Health
The University of Texas MD Anderson Cancer Center
Houston, TX, United States

Disclosure(s): No financial relationships to disclose

Slides

Faculty(s)

PP

Peter Pappas, MD

Emeritus Professor of Medicine
Infectious Diseases
University of Alabama at Birmingham
Birmingham, AL, United States

Disclosure(s): Appili Therapeutics: Advisor/Consultant (Ongoing); Astellas Pharma Inc.: Grant/Research Support (Ongoing); Cidara Therapeutics Inc.: Grant/Research Support (Ongoing); F2G Limited: Grant/Research Support (Ongoing), Scientific advisor (Ongoing); Gilead Biosciences: Grant/Research Support (Ongoing); Scynexis Inc.: Grant/Research Support (Ongoing)

Slides
Dimitrios Kontoyiannis, MD

Professor, Infectious Diseases
Infectious Diseases, Infection Control and Employee Health
The University of Texas MD Anderson Cancer Center
Houston, TX, United States

Disclosure(s): No financial relationships to disclose

Slides
Minh-Hong Nguyen, MD (she/her/hers)

Professor of Medicine
University of Pittsburgh
Pittsburgh, PA, United States

Disclosure(s): QPX: Grant/Research Support ()

Slides

Disclosure(s):

Jeniel E. Nett, MD, PhD: No financial relationships to disclose

Dimitrios P. Kontoyiannis, MD: No financial relationships to disclose

Peter G. Pappas, MD: Appili Therapeutics: Advisor/Consultant (Ongoing); Astellas Pharma Inc.: Grant/Research Support (Ongoing); Cidara Therapeutics Inc.: Grant/Research Support (Ongoing); F2G Limited: Grant/Research Support (Ongoing), Scientific advisor (Ongoing); Gilead Biosciences: Grant/Research Support (Ongoing); Scynexis Inc.: Grant/Research Support (Ongoing)

Minh-Hong Nguyen, MD: QPX: Grant/Research Support ()

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe prevalence, diagnosis, and treatment of invasive fungal infections in patients with COVID-19

Presentations:

1:45 PM – 2:10 PM US ET

Candidiasis in the Era of COVID-19
Speaker: Minh-Hong Nguyen, MD (she/her/hers) – University of Pittsburgh
2:10 PM – 2:35 PM US ET

Aspergillosis and COVID-19: What is the Evidence for CAPA?
Speaker: Peter G. Pappas, MD – University of Alabama at Birmingham
2:35 PM – 3:00 PM US ET

Mucormycosis in Patients With COVID-19
Speaker: Dimitrios P. Kontoyiannis, MD – The University of Texas MD Anderson Cancer Center